Cargando…
Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
Renal sympathetic denervation (RDN) has been and is still proposed as a new treatment modality in patients with apparently treatment resistant hypertension (TRH), a condition defined as persistent blood pressure elevation despite prescription of at least 3 antihypertensive drugs including a diuretic...
Autores principales: | Fadl Elmula, Fadl Elmula M., Larstorp, Anne C., Kjeldsen, Sverre E., Persu, Alexandre, Jin, Yu, Staessen, Jan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321349/ https://www.ncbi.nlm.nih.gov/pubmed/25709581 http://dx.doi.org/10.3389/fphys.2015.00009 |
Ejemplares similares
-
Renal Denervation after Symplicity HTN-3: An Update
por: Persu, Alexandre, et al.
Publicado: (2014) -
SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
por: Patel, Hitesh C, et al.
Publicado: (2014) -
Renal denervation after the symplicity HTN-3 trial
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2014) -
SYMPLICITY HTN-3 results to be announced: a mystery or a story foretold?
por: Staessen, Jan A, et al.
Publicado: (2014) -
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2017)